Clinical Trials Browser

Phase 3 × Fallopian Tube Neoplasms × pazopanib × Clear all

NCT00866697 2021-02-16

Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 3 Completed

940 enrolled 23 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms